International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7747828
Original Article
Prevalence of Pulmonary Artery Hypertension and its Correlation with Severity of Bronchiectasis in a Tertiary care Hospital
 ,
 ,
Published
March 18, 2023
Abstract
Background: Pulmonary arterial hypertension (PAH) is a complication of chronic obstructive pulmonary disease (COPD) in advanced stages, and its presence indicates a poor prognosis. Aim of the study: The study aimed to find out the Prevalence of Pulmonary Artery Hypertension and its Correlation with the Severity of Bronchiectasis in a Tertiary Care Hospital. Methods: In this observational cross-sectional study we enrolled and analyzed 34 patients. The study was considered at the department of Cardiology, at Khulna Medical College and Hospital, Khulna, Bangladesh. The analysis was performed on patients who were admitted with chronic lung disease and the study duration was one year from June 2021 to July 2022. Result: The prevalence and severity of pulmonary hypertension; more than 60% of patients had pulmonary hypertension, and 40% had no complications (Table 2). According to comorbidities, 34 patients have diabetes, and 24 suffer from hypertension (Table 3). The echo findings of the study population are based on Pulmonary artery pressure (N=13), TAPSE (N=8) and FAC (N=13). Conclusion: It is essential to evaluate the cardiac status of bronchiectasis patients at the time of diagnosis as cardiac manifestations are one of the dreadful complications.
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
1824 Views
449 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved